Prognostic Factors in Bladder Carcinoma

REFERENCES

• Blomjous CEM, Schipper NW, Bank JPA, van Galen EM, de Voogt HJ, Meyer CJLM. Retrospective study of prognostic importance of DNA flow-cytometry of urinary bladder carcinoma. J Clin Pathol 1988; 41: 21–25.
   PubMedGoogle Scholar
• Brosman SA. The use of bacillus Calmette-Guérin in the therapy of bladder carcinoma in situ. J Urol 1985; 134: 36–39.
   PubMedGoogle Scholar
• Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD. Superficial bladder tumors (stage pTa, grades 1 and 2): The importance of recurrence pattern following initial resection. J Urol 1986; 135: 920–922.
   PubMedGoogle Scholar
• Gundersen HJG, Jensen EB. Stereological estimation of the volume-weighted mean volume of arbitrary particles observed on random sections. J Microsc 1985; 138: 127–142.
   PubMed Web of Science ®Google Scholar
• Gustafson H, Tribukait B. Characterization of bladder carcinoma by flow DNA analysis. Eur Urol 1985; 11: 410–417.
   PubMed Web of Science ®Google Scholar
• Hald T, Rasmussen F. Extraperitoneal pelvioscopy: A new aid in Staging of lower urinary tract tumors. A preliminary report. J Urol 1980; 124: 245–248.
   PubMed Web of Science ®Google Scholar
• Harving N, Wolf H, Melsen F. Positive urinary cytology alter tumor resection: An indicator for concomitant carcinoma in situ. J Urol 1988; 140: 495–497.
   PubMedGoogle Scholar
• Nemoto R, Uchida K, Hattori K, Shimazui T, Nishijima Y, Saito S, Koiso K, Harada M. S phase fraction of human bladder tumor measured in situ with bromodesoxyuridine labelling. J Urol 1988; 139: 286–289.
   PubMed Web of Science ®Google Scholar
• Nielsen K, Colstrup H, Nilsson T, Gundersen HJG. Stereological estimate of nuclear volume correlated with histopalological grading and prognosis of bladder tumor. Virchow Arch (Cell Pathol) 1986; 52: 41–54.
   Google Scholar
• Nielsen K, Ørntoft T, Wolf H. Stereologic estimates of nuclear volume in non-invasive bladder tumors (Ta) correlated with the recurrence pattern. Cancer 1989; 64: 2269–2274.
   PubMed Web of Science ®Google Scholar
• Olsen PR, Wolf H, Schröder T, Fischer A, Højgaard K. Urothelial atypia and survival rate of 500 unselected patients with primary transitional-cell tumor of the urinary bladder. Scand J Urol Nephrol 1988; 22: 257–263.
   PubMedGoogle Scholar
• Pryor JP. Factors influencing the survival of patients with transitional cell carcinoma of the urinary bladder. Brit J Urol 1973; 45: 586–592.
   PubMedGoogle Scholar
• Quilty PM, Duncan W. Primary radical radiotherapy for T3 transitional cell cancer of the bladder: An analysis of survival and control. Int J Rad Oncol Biol Phys 1986; 12: 853–860.
   PubMed Web of Science ®Google Scholar
• Quilty PM, Hargreve TB, Smith G, Duncan W. Do normal mucosal biopsies predict prognosis in patients with transitional cell carcinoma of bladder treated by radical radiotherapy? Brit J Urol 1987; 59: 242–247.
   PubMedGoogle Scholar
• Richards B, Aso Y, Bollack C, Fossa SD, Koontz WW, Matsuda M, Matsumoto K, Prout GR, van der Werf-Messing B, Wolf H. Prognostic Factors in Infiltrating Bladder Cancer. In ‘Developments in Bladder Cancer. Progress in Clinical and Biological Research’, vol. 221. Denis L, Niijima T, Prout GR, Schröder FJ (editors). pp. 271–286. Alan Liss, New York, 1986.
   Google Scholar
• Shipley WV, Rose MA, Perrone TL, Mannix CM, Heney NM and Prout GR. Full-dose irradiation for patients with invasive bladder carcinoma: Clinical and histological factors prognostic of improved survival. J Urol 1985; 134: 679–683.
   PubMed Web of Science ®Google Scholar
• Skinner DG. Management of invasive bladder cancer: A meticulous pelvic node dissection can make a difference. J Urol 1982; 128: 34–36.
   PubMed Web of Science ®Google Scholar
• Smith G, Elton RA, Chisholm GD, Newsan JE, Hargreve TB. Superficial bladder cancer: Intravesical chemotherapy and tumor progression to muscle invasion or metastases. Brit J Urol 1986; 58: 659–663.
   PubMedGoogle Scholar
• Utz DC, Farrow GM, Rife CC, Segura JW, Zincke H. Carcinoma in situ of the bladder. Cancer 1980; 45: 1842–1848.
   PubMed Web of Science ®Google Scholar
• Wijnmaalen A, van der Werf-Messing BHP. Factors influencing the prognosis in bladder cancer. Int J Rad Oncol Biol Phys 1986; 12: 559–565.
   PubMedGoogle Scholar
• Vindeløv L, Christensen IJ, Engelholm SAa, Guldhammer B, Højgaard K, Panduro J, Sørensen BL, Walbom S, Wolf H. Flow cytometric analysis of 251 transitional cell carcinomas of the bladder. XXI Congress of the International Society of Urology. Abstract 35. Buenos Aires, October 9–14, 1988.
   Google Scholar
• Wolf H, Højgaard K. Urothelial dysplasia concomitant with bladder tumors as a determinant factor for future new occurrences. Lancet 1983; II: 134–136.
   Google Scholar
• Wolf H, Olsen PR, Højgaard K. Urothelial dysplasia concomitant with bladder tumors: A determinant for future new occurrence in patients treated by full-course radiotherapy. Lancet 1985; I: 1005–1008.
   Google Scholar
• Wolf H, Kakizoe T, Smith PH, Brosman SA, Okajima E, Rübben H, Utz DC. Bladder tumors. Treated Natural History. In 'Developments in Bladder Cancer. Progress in Clinical and Biological Research', vol. 221. Denis L, Niijima T, Prout GR, Schrøder FH (editors). Pp 223–255. Alan Liss, New York, 1986.
   Google Scholar
• Wolf H, Iversen H-G, Olsen PR, Schrder T. Transurethral surgery in the treatment of invasive bladder cancer (T1 and T2). Scand J Urol Nephrol 1987; suppl. 104: 127–132.
   Google Scholar
• Wolf H, Olsen PR, Fischer A, Højgaard K. Urothelial atypia concomitant with primary bladder tumor. Incidence in a consecutive series of 500 unselected patients. Scand J Urol Nephrol 1987; 21: 33–38.
   PubMed Web of Science ®Google Scholar
• Ørntoft TF, Nielsen MJ, Wolf H, Olsen S, Clausen H, Hakomori S, Dabelsteen E. Blood group AB0 and Lewis antigen expression during neoplastic progression of human urothelium: Immunohistologic study of type 1 chain structures. Cancer 1987; 60: 2641–2648.
   PubMedGoogle Scholar
• Ørntoft TF, Wolf H, Clausen H, Dabelsteen E, Hakomori S. Blood group ABH-related antigens in normal and malignant bladder urothelium: Possible structural basis for the detection of type 2 chain ABH antigens in invasive carcinomas. Int J Cancer 1989; 43: 774–780.
   PubMedGoogle Scholar
• Ørntoft TF, Pedersen SE, Wolf H. Dual parameter How cytometry of transitional cell carcinoma. Quantitation of DNA content and binding of carbohydrate ligands in cellular subpopulation. Cancer 1988; 61: 963–970.
   PubMedGoogle Scholar